Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 258

1.

Correction: The pleiotropic effects of TNFα in breast cancer subtypes is regulated by TNFAIP3/A20.

Lee E, Ouzounova M, Piranlioglu R, Ma MT, Guzel M, Marasco D, Chadli A, Gestwicki JE, Cowell JK, Wicha MS, Hassan KA, Korkaya H.

Oncogene. 2019 Jun 13. doi: 10.1038/s41388-019-0838-y. [Epub ahead of print]

PMID:
31197211
2.

Plasticity and Potency of Mammary Stem Cell Subsets During Mammary Gland Development.

Lee E, Piranlioglu R, Wicha MS, Korkaya H.

Int J Mol Sci. 2019 May 13;20(9). pii: E2357. doi: 10.3390/ijms20092357. Review.

3.

Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model.

Piranlioglu R, Lee E, Ouzounova M, Bollag RJ, Vinyard AH, Arbab AS, Marasco D, Guzel M, Cowell JK, Thangaraju M, Chadli A, Hassan KA, Wicha MS, Celis E, Korkaya H.

Nat Commun. 2019 Mar 29;10(1):1430. doi: 10.1038/s41467-019-09015-1.

4.

Biomaterial Scaffolds Recruit an Aggressive Population of Metastatic Tumor Cells In Vivo.

Bushnell GG, Hardas TP, Hartfield RM, Zhang Y, Oakes RS, Ronquist S, Chen H, Rajapakse I, Wicha MS, Jeruss JS, Shea LD.

Cancer Res. 2019 Apr 15;79(8):2042-2053. doi: 10.1158/0008-5472.CAN-18-2502. Epub 2019 Feb 26.

PMID:
30808673
5.

Targeting Cancer Stem Cell Redox Metabolism to Enhance Therapy Responses.

Luo M, Wicha MS.

Semin Radiat Oncol. 2019 Jan;29(1):42-54. doi: 10.1016/j.semradonc.2018.10.003. Review.

PMID:
30573183
6.

Ablation of Cancer Stem Cells by Therapeutic Inhibition of the MDM2-p53 Interaction in Mucoepidermoid Carcinoma.

Andrews A, Warner K, Rodriguez-Ramirez C, Pearson AT, Nör F, Zhang Z, Kerk S, Kulkarni A, Helman JI, Brenner JC, Wicha MS, Wang S, Nör JE.

Clin Cancer Res. 2019 Mar 1;25(5):1588-1600. doi: 10.1158/1078-0432.CCR-17-2730. Epub 2018 Nov 29.

PMID:
30498096
7.

Morphology-based prediction of cancer cell migration using an artificial neural network and a random decision forest.

Zhang Z, Chen L, Humphries B, Brien R, Wicha MS, Luker KE, Luker GD, Chen YC, Yoon E.

Integr Biol (Camb). 2018 Dec 19;10(12):758-767. doi: 10.1039/c8ib00106e.

PMID:
30420987
8.

Androgen Receptor and ALDH1 Expression Among Internationally Diverse Patient Populations.

Jiagge E, Jibril AS, Davis M, Murga-Zamalloa C, Kleer CG, Gyan K, Divine G, Hoenerhoff M, Bensenhave J, Awuah B, Oppong J, Adjei E, Salem B, Toy K, Merajver S, Wicha M, Newman L.

J Glob Oncol. 2018 Oct;4:1-8. doi: 10.1200/JGO.18.00056.

PMID:
30307804
9.

Divergent Matrix-Remodeling Strategies Distinguish Developmental from Neoplastic Mammary Epithelial Cell Invasion Programs.

Feinberg TY, Zheng H, Liu R, Wicha MS, Yu SM, Weiss SJ.

Dev Cell. 2018 Oct 22;47(2):145-160.e6. doi: 10.1016/j.devcel.2018.08.025. Epub 2018 Sep 27.

PMID:
30269950
10.

The molecular and phenotypic characterization of fructophilic lactic acid bacteria isolated from the guts of Apis mellifera L. derived from a Polish apiary.

Pachla A, Wicha M, Ptaszyńska AA, Borsuk G, -Trokenheim ŁŁ, Małek W.

J Appl Genet. 2018 Nov;59(4):503-514. doi: 10.1007/s13353-018-0467-0. Epub 2018 Sep 29.

PMID:
30269313
11.

Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer.

Lin CC, Lo MC, Moody R, Jiang H, Harouaka R, Stevers N, Tinsley S, Gasparyan M, Wicha M, Sun D.

Cancer Lett. 2018 Dec 1;438:165-173. doi: 10.1016/j.canlet.2018.09.022. Epub 2018 Sep 15.

PMID:
30227220
12.

The pleiotropic effects of TNFα in breast cancer subtypes is regulated by TNFAIP3/A20.

Lee E, Ouzounova M, Piranlioglu R, Ma MT, Guzel M, Marasco D, Chadli A, Gestwicki JE, Cowell JK, Wicha MS, Hassan KA, Korkaya H.

Oncogene. 2019 Jan;38(4):469-482. doi: 10.1038/s41388-018-0472-0. Epub 2018 Aug 30. Erratum in: Oncogene. 2019 Jun 13;:.

PMID:
30166590
13.

Cancer Stem Cell Vaccination With PD-L1 and CTLA-4 Blockades Enhances the Eradication of Melanoma Stem Cells in a Mouse Tumor Model.

Zheng F, Dang J, Zhang H, Xu F, Ba D, Zhang B, Cheng F, Chang AE, Wicha MS, Li Q.

J Immunother. 2018 Oct;41(8):361-368. doi: 10.1097/CJI.0000000000000242.

PMID:
30063587
14.

Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling.

Luo M, Shang L, Brooks MD, Jiagge E, Zhu Y, Buschhaus JM, Conley S, Fath MA, Davis A, Gheordunescu E, Wang Y, Harouaka R, Lozier A, Triner D, McDermott S, Merajver SD, Luker GD, Spitz DR, Wicha MS.

Cell Metab. 2018 Jul 3;28(1):69-86.e6. doi: 10.1016/j.cmet.2018.06.006.

PMID:
29972798
15.

FGFR signaling regulates resistance of head and neck cancer stem cells to cisplatin.

McDermott SC, Rodriguez-Ramirez C, McDermott SP, Wicha MS, Nör JE.

Oncotarget. 2018 May 18;9(38):25148-25165. doi: 10.18632/oncotarget.25358. eCollection 2018 May 18.

16.

Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer.

Li W, Tanikawa T, Kryczek I, Xia H, Li G, Wu K, Wei S, Zhao L, Vatan L, Wen B, Shu P, Sun D, Kleer C, Wicha M, Sabel M, Tao K, Wang G, Zou W.

Cell Metab. 2018 Jul 3;28(1):87-103.e6. doi: 10.1016/j.cmet.2018.04.022. Epub 2018 May 24.

PMID:
29805099
17.

Asparagine and Glutamine: Co-conspirators Fueling Metastasis.

Luo M, Brooks M, Wicha MS.

Cell Metab. 2018 May 1;27(5):947-949. doi: 10.1016/j.cmet.2018.04.012.

18.

Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression.

Lin H, Wei S, Hurt EM, Green MD, Zhao L, Vatan L, Szeliga W, Herbst R, Harms PW, Fecher LA, Vats P, Chinnaiyan AM, Lao CD, Lawrence TS, Wicha M, Hamanishi J, Mandai M, Kryczek I, Zou W.

J Clin Invest. 2018 Apr 2;128(4):1708. doi: 10.1172/JCI120803. Epub 2018 Apr 2. No abstract available.

19.

Heterogeneity of Human Breast Stem and Progenitor Cells as Revealed by Transcriptional Profiling.

Colacino JA, Azizi E, Brooks MD, Harouaka R, Fouladdel S, McDermott SP, Lee M, Hill D, Madden J, Boerner J, Cote ML, Sartor MA, Rozek LS, Wicha MS.

Stem Cell Reports. 2018 May 8;10(5):1596-1609. doi: 10.1016/j.stemcr.2018.03.001. Epub 2018 Mar 29.

20.

Tamoxifen and ERα36: Fertilizing the seeds of breast cancer metastasis.

Burness ML, Wicha MS.

Cell Res. 2018 Apr;28(4):391-392. doi: 10.1038/s41422-018-0028-4. No abstract available.

21.

Transcriptional profiles of different states of cancer stem cells in triple-negative breast cancer.

Liu M, Liu Y, Deng L, Wang D, He X, Zhou L, Wicha MS, Bai F, Liu S.

Mol Cancer. 2018 Feb 23;17(1):65. doi: 10.1186/s12943-018-0809-x.

22.

Identification, isolation and characterization of human LGR5-positive colon adenoma cells.

Dame MK, Attili D, McClintock SD, Dedhia PH, Ouillette P, Hardt O, Chin AM, Xue X, Laliberte J, Katz EL, Newsome GM, Hill DR, Miller AJ, Tsai YH, Agorku D, Altheim CH, Bosio A, Simon B, Samuelson LC, Stoerker JA, Appelman HD, Varani J, Wicha MS, Brenner DE, Shah YM, Spence JR, Colacino JA.

Development. 2018 Mar 14;145(6). pii: dev153049. doi: 10.1242/dev.153049.

23.

Development and Application of Cancer Stem Cell-Targeted Vaccine in Cancer Immunotherapy.

Lin M, Chang AE, Wicha M, Li Q, Huang S.

J Vaccines Vaccin. 2017;8(6). pii: 371. doi: 10.4172/2157-7560.1000371. Epub 2017 Oct 31. No abstract available.

24.

Modeling of Interactions between Cancer Stem Cells and their Microenvironment: Predicting Clinical Response.

Sehl ME, Wicha MS.

Methods Mol Biol. 2018;1711:333-349. doi: 10.1007/978-1-4939-7493-1_16. Review.

25.

Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression.

Lin H, Wei S, Hurt EM, Green MD, Zhao L, Vatan L, Szeliga W, Herbst R, Harms PW, Fecher LA, Vats P, Chinnaiyan AM, Lao CD, Lawrence TS, Wicha M, Hamanishi J, Mandai M, Kryczek I, Zou W.

J Clin Invest. 2018 Feb 1;128(2):805-815. doi: 10.1172/JCI96113. Epub 2018 Jan 16. Erratum in: J Clin Invest. 2018 Apr 2;128(4):1708.

26.

Algorithm for cellular reprogramming.

Ronquist S, Patterson G, Muir LA, Lindsly S, Chen H, Brown M, Wicha MS, Bloch A, Brockett R, Rajapakse I.

Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):11832-11837. doi: 10.1073/pnas.1712350114. Epub 2017 Oct 24.

27.

A method to reduce ancestry related germline false positives in tumor only somatic variant calling.

Halperin RF, Carpten JD, Manojlovic Z, Aldrich J, Keats J, Byron S, Liang WS, Russell M, Enriquez D, Claasen A, Cherni I, Awuah B, Oppong J, Wicha MS, Newman LA, Jaigge E, Kim S, Craig DW.

BMC Med Genomics. 2017 Oct 19;10(1):61. doi: 10.1186/s12920-017-0296-8.

28.

IL6 blockade potentiates the anti-tumor effects of γ-secretase inhibitors in Notch3-expressing breast cancer.

Wang D, Xu J, Liu B, He X, Zhou L, Hu X, Qiao F, Zhang A, Xu X, Zhang H, Wicha MS, Zhang L, Shao ZM, Liu S.

Cell Death Differ. 2018 Feb;25(2):330-339. doi: 10.1038/cdd.2017.162. Epub 2017 Oct 13.

29.

High-Throughput Microfluidic Labyrinth for the Label-free Isolation of Circulating Tumor Cells.

Lin E, Rivera-Báez L, Fouladdel S, Yoon HJ, Guthrie S, Wieger J, Deol Y, Keller E, Sahai V, Simeone DM, Burness ML, Azizi E, Wicha MS, Nagrath S.

Cell Syst. 2017 Sep 27;5(3):295-304.e4. doi: 10.1016/j.cels.2017.08.012. Epub 2017 Sep 20.

30.

Inhibition of FAK kinase activity preferentially targets cancer stem cells.

Kolev VN, Tam WF, Wright QG, McDermott SP, Vidal CM, Shapiro IM, Xu Q, Wicha MS, Pachter JA, Weaver DT.

Oncotarget. 2017 Jun 16;8(31):51733-51747. doi: 10.18632/oncotarget.18517. eCollection 2017 Aug 1.

31.

Breast Cancer and African Ancestry: Lessons Learned at the 10-Year Anniversary of the Ghana-Michigan Research Partnership and International Breast Registry.

Jiagge E, Oppong JK, Bensenhaver J, Aitpillah F, Gyan K, Kyei I, Osei-Bonsu E, Adjei E, Ohene-Yeboah M, Toy K, Jackson KE, Akpaloo M, Acheampong D, Antwi B, Agyeman FO, Alhassan Z, Fondjo LA, Owusu-Afriyie O, Brewer RN, Gyamfuah A, Salem B, Johnson T, Wicha M, Merajver S, Kleer C, Pang J, Amankwaa-Frempong E, Stark A, Abantanga F, Newman L, Awuah B.

J Glob Oncol. 2016 Jul 27;2(5):302-310. doi: 10.1200/JGO.2015.002881. eCollection 2016 Oct.

32.

Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers.

Murlidhar V, Reddy RM, Fouladdel S, Zhao L, Ishikawa MK, Grabauskiene S, Zhang Z, Lin J, Chang AC, Carrott P, Lynch WR, Orringer MB, Kumar-Sinha C, Palanisamy N, Beer DG, Wicha MS, Ramnath N, Azizi E, Nagrath S.

Cancer Res. 2017 Sep 15;77(18):5194-5206. doi: 10.1158/0008-5472.CAN-16-2072. Epub 2017 Jul 17.

33.

Dendritic-cell-based immunotherapy evokes potent anti-tumor immune responses in CD105+ human renal cancer stem cells.

Zhang XF, Weng DS, Pan K, Zhou ZQ, Pan QZ, Zhao JJ, Tang Y, Jiang SS, Chen CL, Li YQ, Zhang HX, Chang AE, Wicha MS, Zeng YX, Li Q, Xia JC.

Mol Carcinog. 2017 Nov;56(11):2499-2511. doi: 10.1002/mc.22697. Epub 2017 Sep 14.

34.

EMP2 is a novel therapeutic target for endometrial cancer stem cells.

Kiyohara MH, Dillard C, Tsui J, Kim SR, Lu J, Sachdev D, Goodglick L, Tong M, Torous VF, Aryasomayajula C, Wang W, Najafzadeh P, Gordon LK, Braun J, McDermott S, Wicha MS, Wadehra M.

Oncogene. 2017 Oct 19;36(42):5793-5807. doi: 10.1038/onc.2017.142. Epub 2017 Jun 12.

35.

Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy.

Nagarsheth N, Wicha MS, Zou W.

Nat Rev Immunol. 2017 Sep;17(9):559-572. doi: 10.1038/nri.2017.49. Epub 2017 May 30. Review.

36.

Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2-Negative Metastatic Breast Cancer.

Schott AF, Goldstein LJ, Cristofanilli M, Ruffini PA, McCanna S, Reuben JM, Perez RP, Kato G, Wicha M.

Clin Cancer Res. 2017 Sep 15;23(18):5358-5365. doi: 10.1158/1078-0432.CCR-16-2748. Epub 2017 May 24.

37.

Selective Photomechanical Detachment and Retrieval of Divided Sister Cells from Enclosed Microfluidics for Downstream Analyses.

Chen YC, Baac HW, Lee KT, Fouladdel S, Teichert K, Ok JG, Cheng YH, Ingram PN, Hart AJ, Azizi E, Guo LJ, Wicha MS, Yoon E.

ACS Nano. 2017 May 23;11(5):4660-4668. doi: 10.1021/acsnano.7b00413. Epub 2017 May 8.

PMID:
28480715
38.

Microfluidic continuum sorting of sub-populations of tumor cells via surface antibody expression levels.

Jack R, Hussain K, Rodrigues D, Zeinali M, Azizi E, Wicha M, Simeone DM, Nagrath S.

Lab Chip. 2017 Mar 29;17(7):1349-1358. doi: 10.1039/c6lc01496h.

PMID:
28294230
39.

Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells.

Burnett JP, Lim G, Li Y, Shah RB, Lim R, Paholak HJ, McDermott SP, Sun L, Tsume Y, Bai S, Wicha MS, Sun D, Zhang T.

Cancer Lett. 2017 May 28;394:52-64. doi: 10.1016/j.canlet.2017.02.023. Epub 2017 Feb 27.

PMID:
28254410
40.

Single Amino Acid Variant Profiles of Subpopulations in the MCF-7 Breast Cancer Cell Line.

Tan Z, Nie S, McDermott SP, Wicha MS, Lubman DM.

J Proteome Res. 2017 Feb 3;16(2):842-851. doi: 10.1021/acs.jproteome.6b00824. Epub 2017 Jan 20.

41.

RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer.

Liu Y, Burness ML, Martin-Trevino R, Guy J, Bai S, Harouaka R, Brooks MD, Shang L, Fox A, Luther TK, Davis A, Baker TL, Colacino J, Clouthier SG, Shao ZM, Wicha MS, Liu S.

Clin Cancer Res. 2017 Jan 15;23(2):514-522. doi: 10.1158/1078-0432.CCR-15-1348. Epub 2016 Dec 29.

42.

Patient-derived xenograft (PDX) models in basic and translational breast cancer research.

Dobrolecki LE, Airhart SD, Alferez DG, Aparicio S, Behbod F, Bentires-Alj M, Brisken C, Bult CJ, Cai S, Clarke RB, Dowst H, Ellis MJ, Gonzalez-Suarez E, Iggo RD, Kabos P, Li S, Lindeman GJ, Marangoni E, McCoy A, Meric-Bernstam F, Piwnica-Worms H, Poupon MF, Reis-Filho J, Sartorius CA, Scabia V, Sflomos G, Tu Y, Vaillant F, Visvader JE, Welm A, Wicha MS, Lewis MT.

Cancer Metastasis Rev. 2016 Dec;35(4):547-573. doi: 10.1007/s10555-016-9653-x. Review.

43.

5T4-Targeted Therapy Ablates Cancer Stem Cells and Prevents Recurrence of Head and Neck Squamous Cell Carcinoma.

Kerk SA, Finkel KA, Pearson AT, Warner KA, Zhang Z, Nör F, Wagner VP, Vargas PA, Wicha MS, Hurt EM, Hollingsworth RE, Tice DA, Nör JE.

Clin Cancer Res. 2017 May 15;23(10):2516-2527. doi: 10.1158/1078-0432.CCR-16-1834. Epub 2016 Oct 25.

44.

Ultra-Specific Isolation of Circulating Tumor Cells Enables Rare-Cell RNA Profiling.

Jack RM, Grafton MM, Rodrigues D, Giraldez MD, Griffith C, Cieslak R, Zeinali M, Kumar Sinha C, Azizi E, Wicha M, Tewari M, Simeone DM, Nagrath S.

Adv Sci (Weinh). 2016 Apr 18;3(9):1600063. eCollection 2016 Sep.

45.

Comparative Analysis of Breast Cancer Phenotypes in African American, White American, and West Versus East African patients: Correlation Between African Ancestry and Triple-Negative Breast Cancer.

Jiagge E, Jibril AS, Chitale D, Bensenhaver JM, Awuah B, Hoenerhoff M, Adjei E, Bekele M, Abebe E, Nathanson SD, Gyan K, Salem B, Oppong J, Aitpillah F, Kyei I, Bonsu EO, Proctor E, Merajver SD, Wicha M, Stark A, Newman LA.

Ann Surg Oncol. 2016 Nov;23(12):3843-3849. Epub 2016 Jul 28.

PMID:
27469125
46.

Elimination of epithelial-like and mesenchymal-like breast cancer stem cells to inhibit metastasis following nanoparticle-mediated photothermal therapy.

Paholak HJ, Stevers NO, Chen H, Burnett JP, He M, Korkaya H, McDermott SP, Deol Y, Clouthier SG, Luther T, Li Q, Wicha MS, Sun D.

Biomaterials. 2016 Oct;104:145-57. doi: 10.1016/j.biomaterials.2016.06.045. Epub 2016 Jun 23.

47.

Evaluation of the immunogenicity of ALDH(high) human head and neck squamous cell carcinoma cancer stem cells in vitro.

Prince MEP, Zhou L, Moyer JS, Tao H, Lu L, Owen J, Etigen M, Zheng F, Chang AE, Xia J, Wolf G, Wicha MS, Huang S, Ren X, Li Q.

Oral Oncol. 2016 Aug;59:30-42. doi: 10.1016/j.oraloncology.2016.05.013.

48.

Single cell dual adherent-suspension co-culture micro-environment for studying tumor-stromal interactions with functionally selected cancer stem-like cells.

Chen YC, Zhang Z, Fouladdel S, Deol Y, Ingram PN, McDermott SP, Azizi E, Wicha MS, Yoon E.

Lab Chip. 2016 Aug 7;16(15):2935-45. doi: 10.1039/c6lc00062b. Epub 2016 Jul 6.

49.

Therapeutic Efficacy of Cancer Stem Cell Vaccines in the Adjuvant Setting.

Hu Y, Lu L, Xia Y, Chen X, Chang AE, Hollingsworth RE, Hurt E, Owen J, Moyer JS, Prince ME, Dai F, Bao Y, Wang Y, Whitfield J, Xia JC, Huang S, Wicha MS, Li Q.

Cancer Res. 2016 Aug 15;76(16):4661-72. doi: 10.1158/0008-5472.CAN-15-2664. Epub 2016 Jun 20.

50.

Transcriptomic profiling of curcumin-treated human breast stem cells identifies a role for stearoyl-coa desaturase in breast cancer prevention.

Colacino JA, McDermott SP, Sartor MA, Wicha MS, Rozek LS.

Breast Cancer Res Treat. 2016 Jul;158(1):29-41. doi: 10.1007/s10549-016-3854-4. Epub 2016 Jun 15.

Supplemental Content

Support Center